Device Trial Radar · NCT04383145
A Study in Patients With Thoracoabdominal Aortic Aneurysm Treated With the E-nside TAAA Multibranch Stent Graft System
Last checked: Nov 20, 2026Latest source record: Feb 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Jul 15, 2020
Primary completion
Feb 1, 2025
Study completion Feb 28, 2030
Sponsor
- Lead sponsor
- JOTEC GmbHNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 12, 2020
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The INNER-B post-market clinical follow-up study is undertaken to evaluate the prevention of death related to a thoracoabdominal aneurysm when treated by the E-nside TAAA Multibranch Stent Graft System. The secondary objective is to evaluate the safety and clinical performance of the device.
Conditions
- Vascular Aneurysm
Interventions
endovascular repairDevice
Endovascular repair of thoracoabdominal aneurysm using stent grafts.
Primary outcomes
What the sponsor says the trial is designed to measure.
- MortalityTime frame: 30-day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Universitätsklinikum Heidelberg
Heidelberg, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.